Articles by F Van de Werf (4)

Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy

M Swinnen, D Vanhoutte, G. C Van Almen, N Hamdani, M. W.M Schellings, J D'hooge, J Van der Velden, M. S Weaver, E. H Sage, P Bornstein, F. K Verheyen, T VandenDriessche, M. K Chuah, D Westermann, W. J Paulus, F Van de Werf, B Schroen, P Carmeliet, Y. M Pinto and S. Heymans

Circulation 120 ( 16 ): 1585 - 1597 , 2009

A Model for Predicting Mortality in Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Results From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

A Stebbins, R. H Mehta, P. W Armstrong, K. L Lee, C Hamm, F Van de Werf, S James, T Toftegaard Nielsen, R Seabra Gomes, H. D White, C. B Granger and for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators)

Circulation: Cardiovascular Interventions 3 ( 5 ): 414 - 422 , 2010

Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction

J Ganame, G Messalli, S Dymarkowski, F. E Rademakers, W Desmet, F Van de Werf and J. Bogaert

European Heart Journal 30 ( 12 ): 1440 - 1449 , 2009

Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT)

C Berry, K. S Pieper, H. D White, S. D Solomon, F Van de Werf, E. J Velazquez, A. P Maggioni, R. M Califf, M. A Pfeffer and J. J.V. McMurray

European Heart Journal 30 ( 12 ): 1450 - 1456 , 2009

Do you have a suggestion for journals

Suggest Journal